DJ Proposed Placing and WRAP Retail Offer
M&G Credit Income Investment Trust plc (MGCI)
Proposed Placing and WRAP Retail Offer
18-Sep-2026 / 07:00 GMT/BST
=----------------------------------------------------------------------------------------------------------------------
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED
STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER
JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE
LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.
18 September 2026
M&G Credit Income Investment Trust plc
Proposed Placing and WRAP Retail Offer
The Board of M&G Credit Income Investment Trust plc (the "Company") is pleased to announce a placing (the "Placing")
and retail offer of ordinary shares in the Company ("Ordinary Shares") (the "Fundraising"). The retail offer will be
undertaken via the Winterflood Retail Access Platform ("WRAP") (the "WRAP Retail Offer").
Background
The Company has continued to see strong demand for its Ordinary Shares in the market and in response to this, and
through application of the Board's zero discount policy, the Company has issued or sold from treasury 18,425,000
Ordinary Shares in the last 12 months.
The Company offers a compelling investment opportunity for investors seeking attractive long-term yield with low NAV
volatility through a high-quality, diversified portfolio of public and private credit investments. The strategy has a
strong track record of delivering reliable income and resilient performance across market cycles. Combining the very
best of M&G's heritage and scale in credit investing with nearly three decades of private credit experience, attractive
fixed income expertise and one of the largest credit research teams in Europe, the Investment Manager is uniquely
positioned to capture opportunities across the full breadth of credit markets.
The Fundraising
In light of the ongoing demand in the market for Ordinary Shares the Board has decided to undertake the Fundraising.
Any new Ordinary Shares issued pursuant to the Fundraising will be issued at a price equal to a 1.5% premium to the
last published cum-income net asset value per Ordinary Share prior to the closing of the Fundraising (the "Issue Price
"). The Issue Price is expected to be announced on 16 October 2026. The new Ordinary Shares will not be subject to
stamp duty.
The net proceeds of the Fundraising will be invested in accordance with the Company's investment policy.
Marex Financial ("Marex"), acting through its division Winterflood, is acting as placing agent to the Company in
relation to the Placing. The Placing is not being underwritten.
In order to allow qualifying retail investors to participate in the Fundraising, the Company is undertaking the WRAP
Retail Offer, which is being made under an exception from the prohibition on offers to the public pursuant to Schedule
1 (Part 1) of The Public Offers and Admissions to Trading Regulations 2024 ("POATRs") and under an exemption from the
requirement to publish a prospectus under the FCA Handbook PRM Admission to Trading on a Regulated Market sourcebook.
The WRAP Retail Offer is expected to run alongside the Placing. A separate announcement will be released shortly
detailing the WRAP Retail Offer.
Any new Ordinary Shares issued in connection with the Fundraising will be issued pursuant to the authority granted by
the Company's shareholders at the Company's annual general meeting held on 20 May 2026. The Fundraising may be subject
to scaling back at the sole discretion of the Board, in consultation with Marex.
The new Ordinary Shares will, when issued, be credited as fully paid, and have the right to receive all dividends and
other distributions declared, if any, by reference to a record date after the date of their issue and in all other
respects will rank pari passu with the existing Ordinary Shares.
An application will be made to the London Stock Exchange plc (the "LSE") for admission to trading of the new Ordinary
Shares on its Main Market for listed securities ("Admission").
Further information on the Company can be found at the Company's website: https://www.mandg.com/investments/
private-investor/en-gb/funds/mg-credit-income-investment-trust-plc/gb00bfyyl325.
Timetable
The expected timetable for the Fundraising is as follows:
2026
Fundraising opens 07:00 on 18 September
Issue Price announced 16 October
Fundraising closes 14:00 on 20 October
Results of Fundraising announced 21 October
Admission of new Ordinary Shares 08.00 on 23 October
Availability of the Placing
Participation in the Placing will only be available to persons in the United Kingdom who are qualified investors as defined in paragraph 15 of Schedule 1 to the POATRs ("UK Qualified Investors"). UK Qualified Investors should communicate their firm interest to their usual sales contact at Marex.
The Placing will be made through Marex, subject to the terms and conditions (the "Terms and Conditions") set out below in Appendix 1 to this announcement. The decision to allot the Ordinary Shares to any UK Qualified Investor pursuant to the Placing shall be at the absolute discretion of Marex (in consultation with the Company).
By making an offer to subscribe for Ordinary Shares under the Placing, UK Qualified Investors will be deemed to have accepted the Terms and Conditions. A UK Qualified Investor that has made an offer to subscribe for Ordinary Shares under the Placing accepts that following the closing of the Fundraising such offer shall be irrevocable. Upon being notified of its allocation of Ordinary Shares in the Placing, a UK Qualified Investor shall be contractually committed to acquire the number of Ordinary Shares allocated to it at the Issue Price.
Marex, in agreement with the Company, may choose to accept applications, either in whole or in part, on the basis of allocations determined, and may scale down any applications for this purpose, on such basis as the Company and Marex may determine. Marex may also, notwithstanding the above, subject to the prior consent of the Company: (i) allocate Ordinary Shares after the time of any initial allocation to any UK Qualified Investor submitting an application after that time; and (ii) allocate Ordinary Shares after the Fundraising has closed to any UK Qualified Investor submitting an application after that time.
For Further Information:
MUFG Corporate Governance Limited
mandgcredit@cm.mpms.mufg.com
Company Secretary
+44 (0) 20 3757 1912
Marex Financial +44 (0)20 3100 0000
Neil Morgan
Darren Willis
The Company's LEI is: 549300E9W63X1E5A3N24
Important Notice
The content of this announcement has been prepared by, and is the sole responsibility of M&G Credit Income Investment Trust plc.
The information contained in this announcement is given at the date of its publication and is subject to updating, revision and amendment from time to time. Neither the content of the Company's website nor any website accessible by hyperlinks to the Company's website is incorporated in, or forms part of, this announcement.
Members of the public are not eligible to take part in the Placing. Information in this announcement relating to the Placing (including within Appendix 1) and the terms and conditions of the Placing set out in Appendix 1 are for information purposes only and are directed only at persons who are UK Qualified Investors, who are persons: (i) who have professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) falling within article 49(2)(a) to (d) ("high net worth companies, unincorporated associations, etc") of the Order; or (iii) are persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this announcement relates is available only to and will only be engaged in with the persons referred above.
Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice. Dividend targets are a target only and not a profit forecast, there can be no assurances that this target will be met. No representation is being made by the inclusion of the data contained herein that the Company will achieve results similar to that which it has achieved in the past or avoid losses. Past performance cannot be relied on as a guide to future performance.
It should be noted that a subscription for Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out in the Company's latest annual report before making a decision to subscribe for Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the Ordinary Shares if they are in any doubt. Investors' capital is at risk.
(MORE TO FOLLOW) Dow Jones Newswires
September 18, 2026 02:00 ET (06:00 GMT)
DJ Proposed Placing and WRAP Retail Offer -2-
Any investment or investment activity to which this announcement (including the Appendix) and the terms and conditions set out herein relates is available only to, and will be engaged in only with, Relevant Persons. This announcement (including the Appendix) is for information purposes only and does not itself constitute an offer for sale or subscription of any securities in the Company. If persons are in any doubt as to whether they are a Relevant Person they should consult a professional adviser for advice.
The Ordinary Shares have not been registered and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under the securities laws of any state or other jurisdiction of the United States and may not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to, or for the account or benefit of, any US Person (within the meaning of Regulation S under the Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction in the United States, and under circumstances that would not result in the Company being in violation of the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act"). The Company has not been, and will not be, registered under the Investment Company Act and as such investors are not and will not be entitled to the benefits of the Investment Company Act.
The Ordinary Shares are being offered and sold outside the United States to non-U.S. Persons in offshore transactions in reliance on the exemption from the registration requirements of the Securities Act provided by Regulation S thereunder. There has been and will be no public offering of the Ordinary Shares in the United States. The Ordinary Shares have not been approved or disapproved by the United States Securities and Exchange Commission, any state securities commission in the United States or any other U.S. regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Ordinary Shares pursuant to the Fundraising or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.
This announcement (including Appendix 1) does not constitute an offer to sell or issue or a solicitation to buy or subscribe for Ordinary Shares in any jurisdiction including, without limitation, the United States, Canada, Australia, New Zealand, the Republic of South Africa, Japan or any other jurisdiction in which such offer or solicitation is or may be unlawful (an "Excluded Territory"). This announcement (including Appendix 1) is not for publication, release or distribution, directly or indirectly, in whole or in part, to U.S. Persons or to persons in an Excluded Territory.
The distribution of this announcement (including Appendix 1), and/or the issue of Ordinary Shares in certain jurisdictions may be restricted by law and/or regulation. No action has been taken by the Company, Marex or M&G Alternatives Investment Management Limited (the "Investment Manager") or any of their respective affiliates that would permit an offer of Ordinary Shares pursuant to the Placing in any jurisdiction where action for that purpose is required. Persons receiving this announcement are required to inform themselves about and to observe any such restrictions.
Certain statements made in this announcement (including Appendix 1) are forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Such statements are based on current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements. No assurance can be given that forward-looking statements results will be achieved. The forward-looking statements contained in this announcement speak only as of the date of this announcement and the Company assumes no obligation to, and does not intend to update or revise publicly any of them whether as a result of new information, future events or otherwise, except to the extent required by the FCA, the LSE or by applicable law, the Listing Rules and the Disclosure Guidance and Transparency Rules.
The information contained in this announcement is subject to change without notice and the Company does not take any responsibility or obligation nor does it intend to revise or update publicly or review any of the forward-looking statements in this announcement to reflect events or circumstances after the date of this announcement (except to the extent required by the FCA, the LSE or by applicable law). Prospective investors should not place undue reliance on forward-looking statements, which speak only as of the date of this announcement, as a prediction of actual results or otherwise.
Marex or its affiliates from time to time have provided in the past and may provide in the future investment banking, financial advisory and commercial banking services to the Company and its affiliates in the ordinary course of business for which they have received or may receive customary fees and commissions.
Marex, which is authorised and regulated in the United Kingdom by the FCA, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Marex or advice to any other person in relation to the matter contained herein.
None of the Investment Manager or Marex, or any of their respective affiliates, accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or for any loss howsoever arising from any use of the announcement or its contents aside from the responsibilities and liabilities, if any, which may be imposed by FSMA, or the regulatory regime established thereunder or any other applicable regulatory regime. The Investment Manager and Marex and their respective affiliates accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement or its contents or otherwise arising in connection therewith.
Information to Distributors
Solely for the purposes of the product governance requirements contained within the relevant provisions of the UK statutory instruments implementing Directive 2014/65/EU and Commission Delegated Directive (EU) 2017/593, Regulation (EU) No 600/2014 of the European Parliament, as they form part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (together, the "UK MiFID Laws"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the UK MiFID Laws) may otherwise have with respect thereto, the Ordinary Shares have been subject to a product approval process, which has determined that the Ordinary Shares are: (i) compatible with an end target market of retail investors who do not need a guaranteed income or capital protection and investors who meet the criteria of professional clients and eligible counterparties, each as defined in the UK MiFID Laws; and (ii) eligible for distribution through all distribution channels permitted by the UK MiFID Laws (the "Target Market Assessment").
Notwithstanding the Target Market Assessment, distributors should note that: the price of Ordinary Shares may decline and investors could lose all or part of their investment; the Ordinary Shares offer no guaranteed income and no capital protection; and an investment in Ordinary Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the issue of the Ordinary Shares. Furthermore, it is noted that, notwithstanding the Target Market Assessment, Marex will only contact prospective placees for participation in the Placing who meet the criteria of professional clients and eligible counterparties.
For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of the UK MiFID Laws; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Ordinary Shares.
Each distributor is responsible for undertaking its own target market assessment in respect of the Ordinary Shares and determining appropriate distribution channels.
PRIIPS Regulation
(MORE TO FOLLOW) Dow Jones Newswires
September 18, 2026 02:00 ET (06:00 GMT)
DJ Proposed Placing and WRAP Retail Offer -3-
The Company has prepared a key information document in respect of the Ordinary Shares, which is available to investors on the Company's website: https://www.mandg.com/dam/investments/common/gb/en/documents/funds-literature/ credit-income-investment-trust/credit_income_investment_trust_gbp_-_inc_uk_kid_eng_uk_gb00bfyyl325.pdf. The key information document has been prepared in accordance with the content requirements and methodologies specified in the UK version of Regulation (EU) No 1286/2014 of the European Parliament and of the Council of 26 November 2014 on key information documents for packaged retail and insurance-based investment products, which previously formed part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.
APPENDIX 1 - TERMS AND CONDITIONS OF THE PLACING
1. INTRODUCTION1. By participating in the Placing each applicant for Ordinary Shares (a "Placee") isdeemed to have read and understood this announcement (the "Announcement") including this appendix ("Appendix 1") in its entirety and to be providing the representations, warranties, undertakings, agreements andacknowledgements contained in this Appendix 1.
2. Each Placee which confirms its agreement (whether orally or in writing) to Marex to subscribe for theOrdinary Shares under the Placing will be bound by these Terms and Conditions and will be deemed to have acceptedthem.
3. Marex may require any Placee to agree to such further terms and/or conditions and/or give such additionalwarranties and/or representations as it (in its absolute discretion) sees fit and may require any such Placee toexecute a separate placing letter. The terms and conditions contained in any such placing letter shall besupplemental and in addition to the Terms and Conditions contained in this Appendix 1.
2. AGREEMENT TO SUBSCRIBE FOR ORDINARY SHARES1. Conditional on:
1. Admission occurring and becoming effective by 8:00 a.m. on 23 October 2026 (or such later time and/ordate as the Company and Marex may agree, not being later than 30 November 2026);
2. the Placing not having been terminated on or before the date of Admission; and
3. Marex confirming to the Placees their allocation of Ordinary Shares,
(the "Conditions"),
a Placee agrees to become a member of the Company and agrees to subscribe for those Ordinary Shares allocated to it by Marex at the Issue Price. To the fullest extent permitted by law, each Placee acknowledges and agrees that it will not be entitled to exercise any remedy of rescission at any time. This does not affect any other rights the Placee may have.
2. Any commitment to acquire Ordinary Shares under the Placing agreed orally with Marex, as agent for theCompany, will constitute an irrevocable, legally binding commitment upon that person (who at that point will becomea Placee) in favour of the Company and Marex, to subscribe for the number of Ordinary Shares allocated to it on theterms and subject to the conditions set out in these Terms and Conditions and in a contract note (the "ContractNote") and in accordance with the articles of association of the Company. Except with the consent of Marex, suchoral commitment will not be capable of variation or revocation after the time at which it is made.
3. Each Placee's allocation of Ordinary Shares under the Placing will be evidenced by a Contract Noteconfirming: (i) the number of Ordinary Shares that such Placee has agreed to acquire; (ii) the aggregate amountthat such Placee will be required to pay for such Ordinary Shares; and (iii) settlement instructions to pay Marex,as agent for the Company. The provisions as set out in these Terms and Conditions will be deemed to be incorporatedinto that Contract Note.
3. PAYMENT FOR ORDINARY SHARES
1. Each Placee undertakes to pay the Issue Price for the Ordinary Shares issued to the Placee in the mannerand by the time directed by Marex. In the event of any failure by any Placee to pay as so directed and/or by thetime required by Marex, the relevant Placee's application for Ordinary Shares may, at the discretion of Marex,either be accepted or rejected and, in the former case, paragraph 4.6 and/or 7.5 below shall apply.
4. PARTICIPATION IN, AND PRINCIPAL TERMS OF, THE PLACING
1. Prospective Placees will be identified and contacted by Marex.
2. The latest time and date for receipt of commitments under the Fundraising is 2.00 p.m. (London time) on20 October 2026. Marex reserves the right to bring this date forward, or to extend the timetable at its discretion.
3. Marex will re-contact and confirm orally or by email to Placees the size of their respective allocationsand a Contract Note will be dispatched as soon as possible thereafter. Marex's confirmation of the size ofallocations and each Placee's oral commitment to accept the same or such lesser number as determined in accordancewith paragraph 4.4 below will constitute a legally binding agreement pursuant to which each such Placee will berequired to accept the number of Ordinary Shares allocated to the Placee at the Issue Price and otherwise on theterms and subject to the conditions set out in this Appendix 1.
4. Marex (after consultation with the Company) reserves the right to scale back the number of OrdinaryShares to be subscribed by any Placee in the Placing. The Company and Marex also reserve the right not to acceptoffers to subscribe for Ordinary Shares or to accept such offers in part rather than in whole. Marex shall beentitled to effect the Fundraising by such method as it shall in its sole discretion determine. To the fullestextent permissible by law, neither Marex, nor any holding company of Marex, nor any subsidiary, branch or affiliateof Marex (each an "Affiliate") nor any person acting on behalf of any of the foregoing shall have any liability toPlacees (or to any other person whether acting on behalf of a Placee or otherwise). In particular, neither Marex,nor any Affiliate thereof nor any person acting on their behalf shall have any liability to Placees in respect oftheir conduct of the Placing. No commissions will be paid to Placees or directly by Placees in respect of theOrdinary Shares. Under the terms of the Company's placing agreement with Marex, the Company shall pay Marex acommission equal to a proportion of the gross proceeds raised from Placees.
5. Each Placee's obligations will be owed to the Company and to Marex. Following the oral or emailconfirmation referred to above, each Placee will have an immediate, separate, irrevocable and binding obligation,owed to Marex, to pay to Marex (or as Marex may direct) in cleared funds an amount equal to the product of theIssue Price and the number of Ordinary Shares which such Placee has agreed to acquire under the Placing.Commitments under the Placing, once made, cannot be withdrawn without the consent of the directors of the Company.The Company shall allot such Ordinary Shares to each Placee (or to Marex for onward transmission to the relevantPlacee) following each Placee's payment to Marex of such amount.
6. Each Placee agrees to indemnify on demand and hold each of Marex, the Company and the Investment Managerand its and their respective Affiliates harmless from any and all costs, claims, liabilities and expenses(including legal fees and expenses) arising out of or in connection with any breach of the acknowledgements,undertakings, representations, warranties and agreements set forth in these Terms and Conditions as supplemented byany Placing Letter.
7. All obligations of Marex under the Placing will be subject to fulfilment of the conditions referred tobelow under "Conditions".
5. CONDITIONS
1. If the Placing does not become unconditional, the Placing will lapse and each Placee's rights andobligations under the Placing shall cease and terminate at such time and no claim may be made by a Placee inrespect thereof. Marex shall have no liability to any Placee (or to any other person whether acting on behalf of aPlacee or otherwise) in respect of any decision they may make as to whether or not to waive or to extend the timeand/or date for the satisfaction of any Condition.
2. By participating in the Placing, each Placee agrees that its rights and obligations hereunder terminateonly in the circumstances described above and will not be capable of rescission or termination by the Placee.
3. By participating in the Placing, each Placee agrees with Marex that the exercise by Marex of any right oftermination or other discretion shall be within the absolute discretion of Marex and that Marex needs not make anyreference to the Placee in this regard and that, to the fullest extent permitted by law, Marex shall not have anyliability whatsoever to the Placee in connection with any such exercise.
6. NO PROSPECTUS
1. The Placing is only available to Relevant Persons that are identified and contacted by Marex and theOrdinary Shares will only be offered in such a way as to not require a separate prospectus to be issued in theUnited Kingdom or elsewhere. No offering document or prospectus has been or will be submitted to be approved by theFCA in relation to the Placing and Placees' commitments will be made solely on the basis of the informationcontained in this Announcement (including this Appendix 1) and information that has been published by the Companyin accordance with the FCA's Disclosure Guidance and Transparency Rules and certain business and financialinformation the Company is required to publish in accordance with the rules and practices of the FCA, and theMarket Abuse Regulation (EU Regulation No. 596/2014) as it forms part of United Kingdom law by virtue of theEuropean Union (Withdrawal) Act 2018 (as amended, "UK MAR") (collectively "Exchange Information").
(MORE TO FOLLOW) Dow Jones Newswires
September 18, 2026 02:00 ET (06:00 GMT)
